How do you get approved for Semaglutide GLP-1
Indeed, liraglutide, the first GLP- 1 RA approved for chronic weight management (in 2014) was shown in the SCALE Phase 3 trial to produce mean weight reduction from baseline to week 56, of 8.0% with liraglutide 3.0 mg versus 2.8% with placebo (last-observation-carried-forward imputationLOCF) [3]
Maintaining a calorie deficit is one of the most important aspects of weight loss
In a recent study published in the Journal of Clinical Medicine , a group of researchers described the clinical characteristics of patients with type 2 diabetes (T2D) initiating oral semaglutide and assessed its effects on glycemic control, body weight (BW), and tolerability in routine clinical practice
doi:10.1016/j.diabet.2020.101211
Some diabetes or blood pressure medications may need dose adjustments when you start semaglutide